ProfileGDS5822 / ILMN_1224754
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 97% 96% 96% 95% 97% 96% 94% 95% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 12204.697
GSM1276600PDAC Late Ablation Control 21463.596
GSM1276601PDAC Late Ablation Control 31711.796
GSM1276602PDAC Late Ablation 11088.695
GSM1276603PDAC Late Ablation 22323.897
GSM1276604PDAC Late Ablation 31595.596
GSM1303940PDAC Late Ablation_anti-CTLA4 11048.794
GSM1303941PDAC Late Ablation_anti-CTLA4 21352.295
GSM1303942PDAC Late Ablation_anti-CTLA4 34251.198